产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
Ledipasvir-d6 | L647337-1mg | ≥99% | 2050041-12-6 | 1mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
Ledipasvir-d6 | L647337-10mg | ≥99% | 2050041-12-6 | 10mg | ¥ 15000.9 | 期货,请咨询 | 阿拉丁 |
L-Eflornithine monohydrochloride | L647336-10mg | ≥98% | 69955-42-6 | 10mg | ¥ 1550.9 | 期货,请咨询 | 阿拉丁 |
LP-935509 | L647310-5mg | ≥99% | 1454555-29-3 | 5mg | ¥ 950.9 | 期货,请咨询 | 阿拉丁 |
LP-935509 | L647310-50mg | ≥99% | 1454555-29-3 | 50mg | ¥ 5950.9 | 期货,请咨询 | 阿拉丁 |
LP-935509 | L647310-10mg | ≥99% | 1454555-29-3 | 10mg | ¥ 1650.9 | 期货,请咨询 | 阿拉丁 |
LP-935509 | L647310-100mg | ≥99% | 1454555-29-3 | 100mg | ¥ 10500.9 | 期货,请咨询 | 阿拉丁 |
LCL521 | L647251-5mg | ≥97% | 1226851-11-1 | 5mg | ¥ 3500.9 | 现货 | 阿拉丁 |
LCL521 | L647251-10mg | ≥97% | 1226851-11-1 | 10mg | ¥ 5500.9 | 现货 | 阿拉丁 |
LY309887 | L647242-5mg | ≥98% | 127228-54-0 | 5mg | ¥ 3840.9 | 期货,请咨询 | 阿拉丁 |
LY309887 | L647242-50mg | ≥98% | 127228-54-0 | 50mg | ¥ 22000.9 | 期货,请咨询 | 阿拉丁 |
LY309887 | L647242-25mg | ≥98% | 127228-54-0 | 25mg | ¥ 13500.9 | 期货,请咨询 | 阿拉丁 |
LY309887 | L647242-10mg | ≥98% | 127228-54-0 | 10mg | ¥ 6200.9 | 期货,请咨询 | 阿拉丁 |
LY309887 | L647242-100mg | ≥98% | 127228-54-0 | 100mg | ¥ 33900.9 | 期货,请咨询 | 阿拉丁 |
LY2922470 | L647237-5mg | ≥99% | 1423018-12-5 | 5mg | ¥ 3000.9 | 期货,请咨询 | 阿拉丁 |
LY2922470 | L647237-50mg | ≥99% | 1423018-12-5 | 50mg | ¥ 12000.9 | 期货,请咨询 | 阿拉丁 |
LY2922470 | L647237-1mg | ≥99% | 1423018-12-5 | 1mg | ¥ 1142.9 | 期货,请咨询 | 阿拉丁 |
LY2922470 | L647237-10mg | ≥99% | 1423018-12-5 | 10mg | ¥ 4500.9 | 期货,请咨询 | 阿拉丁 |
LY2922470 | L647237-100mg | ≥99% | 1423018-12-5 | 100mg | ¥ 19000.9 | 期货,请咨询 | 阿拉丁 |
Letrazuril | L647235-5mg | ≥98% | 103337-74-2 | 5mg | ¥ 1900.9 | 期货,请咨询 | 阿拉丁 |
Letrazuril | L647235-50mg | ≥98% | 103337-74-2 | 50mg | ¥ 9700.9 | 期货,请咨询 | 阿拉丁 |
Letrazuril | L647235-10mg | ≥98% | 103337-74-2 | 10mg | ¥ 3250.9 | 期货,请咨询 | 阿拉丁 |
Letrazuril | L647235-100mg | ≥98% | 103337-74-2 | 100mg | ¥ 16500.9 | 期货,请咨询 | 阿拉丁 |
LEI-401 | L647223-5mg | ≥99% | 2393840-15-6 | 5mg | ¥ 1500.9 | 期货,请咨询 | 阿拉丁 |